| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2025 - 31 Dec 2025 | 23 Jan 2026 | 39 | 20% | 79% | 1% | 2% |
| 01 Jan 2025 - 30 Jun 2025 | 25 Jul 2025 | 41 | 18% | 79% | 3% | 3% |
| 01 Jul 2024 - 31 Dec 2024 | 21 Jan 2025 | 40 | 21% | 77% | 2% | 4% |
| 01 Jan 2024 - 30 Jun 2024 | 22 Jul 2024 | 42 | 19% | 78% | 3% | 4% |
| 01 Jul 2023 - 31 Dec 2023 | 26 Jan 2024 | 42 | 19% | 78% | 3% | 5% |
| 01 Jan 2023 - 30 Jun 2023 | 26 Jul 2023 | 43 | 17% | 76% | 7% | 5% |
| 01 Jul 2022 - 31 Dec 2022 | 26 Jan 2023 | 42 | 21% | 73% | 6% | 6% |
| 01 Jan 2022 - 30 Jun 2022 | 25 Jul 2022 | 43 | 31% | 68% | 1% | 6% |
| 01 Jul 2021 - 31 Dec 2021 | 25 Jan 2022 | 34 | 35% | 64% | 1% | 3% |
| 01 Jan 2021 - 30 Jun 2021 | 14 Jul 2021 | 32 | 46% | 53% | 1% | 3% |
| 01 Jul 2020 - 31 Dec 2020 | 19 Jan 2021 | 32 | 37% | 62% | 1% | 3% |
| 01 Jan 2020 - 30 Jun 2020 | 30 Jul 2020 | 27 | 58% | 38% | 4% | 12% |
| 01 Jul 2019 - 31 Dec 2019 | 30 Jan 2020 | 22 | 76% | 23% | 1% | 19% |
| 01 Jul 2018 - 31 Dec 2018 | 10 Jan 2019 | 18 | 86% | 13% | 1% | 19% |
| 01 Jan 2018 - 30 Jun 2018 | 10 Jan 2019 | 21 | 81% | 17% | 2% | 20% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
There are some changes to the standard payment terms where suppliers have reduced payment terms for expedited payments agreed with suppliers at time of contract.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
N/A
Maximum contractual payment period agreed
90
We operate a purchase order system which reduces the number of fee disputes. Any fee disputes are discussed between relevant supplier and the business owner drawing in legal and sourcing support as needed.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
VERTEX PHARMACEUTICALS (EUROPE) LIMITED is a pharmaceutical company that operates in Europe. They are committed to sustainability and have implemented various initiatives to reduce their environmental impact.
One of their key sustainability programs is their Green Teams, which are made up of employees who work to identify and implement eco-friendly practices within the company. They also have an active recycling program and have reduced their carbon footprint by using renewable energy sources.
In terms of products and services, VERTEX PHARMACEUTICALS (EUROPE) LIMITED focuses on developing innovative treatments for serious and life-threatening diseases. They have a strong pipeline of drugs in development for conditions such as cystic fibrosis, sickle cell disease, and alpha-1 antitrypsin deficiency.
The company is led by a team of experienced professionals, including their President and CEO, Dr. Reshma Kewalramani. They also have a dedicated team of scientists and researchers who are constantly working towards developing new treatments.
Contact information for VERTEX PHARMACEUTICALS (EUROPE) LIMITED can be found on their website, including their registered office address in London. Their website also provides information on their products, clinical trials, and sustainability efforts.
In summary, VERTEX PHARMACEUTICALS (EUROPE) LIMITED is a leading pharmaceutical company in Europe, with a strong focus on sustainability and developing groundbreaking treatments for serious diseases. Their commitment to sustainability and dedicated team make them a reputable and responsible company in the pharmaceutical industry.
Proud of your payment record? Show your live score on your own site:
<iframe src="https://paymentcheck.co.uk/badge/02907620" width="240" height="72" style="border:0" title="PaymentCheck Score" loading="lazy"></iframe>